Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMEBACK: Fecal Microbiota Transplantation in Chronic Fatigue Syndrome
NCT03691987Phase 2Completed
- Sponsor
- University Hospital of North Norway
- Start
- Feb 2019
- Primary completion
- Mar 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fecal microbiome transplant in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS) and myalgic encephalomyelitis (ME) (2 arms), sponsored by University Hospital of North Norway. Primary endpoint: Proportion with treatment success in Fatigue Severity Scale score at 3 months. Started Feb 2019; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on NCT03691987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691987.